'Bionanotechnology from Theory to Practice' is a short online, course providing an interdisciplinary and up-to-date overview of the rapidly developing area of bionanotechnology
Page URL: https://www.bionews.org.uk/page_93603

Growth factor from stem cells spurs MS recovery in mice

28 May 2012
Appeared in BioNews 658

chemical produced by stem cells promotes recovery in mice with the autoimmune neurological disease, multiple sclerosis (MS).

Hepatocyte growth factor (HGF), which is produced by human mesenchymal stem cells (hMSCs), appeared to both repair existing damage and prevent future neurological harm in a mouse model of the disease.

hMSCs are already being tested in clinical trials as treatment for autoimmune and neurological conditions. These findings identify HGF as a means by which the cells might exert their protective and regenerative effects in the case of MS.

'The importance of this work is we think we've identified the driver of the recovery', confirmed Professor Robert Miller from Case Western Reserve University School of Medicine in the USA, who led the study.

MS is caused by the body's immune system attacking its own tissue, specifically the protective coating around nerve cells called myelin. Myelin sheaths protect nerve cells from damage and help them conduct electrical signals. Their destruction in MS leads to a progressive loss of motor function, coordination, vision and cognition.

Approximately 100,000 people in the UK have MS and no cure is available. Current treatments focus on suppressing the immune system to prevent further damage and slow disease progression.

Professor Miller's team had previously shown that hMSCs could reverse the symptoms of a mouse model of the disease. In the current study, published in Nature Neuroscience, similar effects were observed when MS mice were injected with only the liquid medium in which the hMSCs were grown.

This suggested recovery was caused by something the cells secreted, which upon further investigation was found to be HGF. Injecting HGF alone decreased levels of substances promoting inflammation and stimulated the re-growth of myelin around damaged nerves.

These findings highlight the potential for a therapy that both prevents further damage and promotes repair. Studies into how to identify HMSCs that produce higher levels of HGF are underway, with the aim of enhancing hMSC-based therapies.

Professor Miller now asks whether 'we could now take away the mesenchymal stem cells and treat only with hepatocyte growth factor. We've shown we can do that in an animal but it's not clear if we can do that in a patient'.

Professor Jacques Gallipeau, co-director of the Emory-Georgia Tech Centre for Regenerative Therapy in the USA, who was not involved in the study, told The Scientist that 'the best cell therapy [would be] done without a cell. Identifying these factors and testing them as single agents is an important short-term deliverable of stem cell science'.

Could Stem Cells Cure MS?
The Scientist |  23 May 2012
Growth factor in stem cells may spur recovery from MS
EurekAlert! |  20 May 2012
Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models
Nature Neuroscience |  20 May 2012
MSC-Secreted Factor Key to Impact of Multiple Sclerosis Cell Therapy
Genetic Engineering and Biotechnology News |  21 May 2012
19 May 2014 - by Alice Plein 
Mice with a viral form of multiple sclerosis are able to walk again after receiving a transplant of human stem cells, scientists report...
7 October 2013 - by Julianna Photopoulos 
A group of international researchers has identified 48 new genetic variants that influence the risk of developing multiple sclerosis. This brings the number of genetic 'risk factors' linked to the disease to 110...
9 September 2013 - by Dr Tamara Hirsch 
Genes involved in replenishing brain cells and their support materials are switched on during sleep, according to a study in mice...
22 April 2013 - by Dr Anna Cauldwell 
Skin cells have been directly converted into the types of cells destroyed in patients with myelin disorders like multiple sclerosis and cerebral palsy in a pair of studies on mice...
15 October 2012 - by Joseph Jebelli 
Scientists have successfully implanted human neural stem cells into the brains of children with a rare neurological disorder...
21 May 2012 - by Victoria Kay 
The world's first stem cell drug has been approved by Canadian authorities. US biotech company, Osiris Therapeutics, has been given the go-ahead to market its drug, Prochymal, for the treatment of graft-versus-host-disease (GvHD) in children who fail to respond to steroids....
15 August 2011 - by Dr Rebecca Hill 
Researchers have identified 29 new genetic variants with a link to multiple sclerosis (MS). This brings the total number of genetic changes associated with the disease, which affects around 2.5 million people worldwide, to nearly 50...
1 August 2011 - by Dr Caroline Hirst 
UK scientists are launching a global clinical trial to test the potential and safety of stem cells to treat multiple sclerosis (MS)...
27 April 2009 - by Alison Cranage 
A report published in the Journal of Translational Medicine shows that stem cells taken from patients' adipose (fat) tissue may be able help relieve the symptoms of multiple sclerosis (MS). In the preliminary study by researchers from Medistem Inc. and the Division of Neurosurgery, University of California...
16 October 2006 - by Dr Jess Buxton 
US researchers have used human stem cells to lessen the symptoms of motor neurone disease in rats bred to have symptoms of the condition. The scientists, based at Johns Hopkins University, Baltimore, showed that injecting fetal nerve stem cells into the spines of rats with amytrophic...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.